Vertex Pharmaceuticals (VRTX) Change in Taxes (2011 - 2012)

Vertex Pharmaceuticals (VRTX) recorded quarterly Change in Taxes of -$3.2 million in Q4 2012, down 185.99% quarter-over-quarter from $3.7 million in Q3 2012, and down 236.03% on a YoY basis from $2.3 million in Q1 2012.

Vertex Pharmaceuticals (VRTX) Change in Taxes (2011 - 2012) Analysis & Trends

Vertex Pharmaceuticals' Change in Taxes history runs 2 years deep, the most recent figure standing at -$3.2 million for Q4 2012.

  • In Q4 2012, Change in Taxes fell 236.03% year-over-year to -$3.2 million; the TTM figure through Dec 2012 stood at -$11.4 million (changed N/A YoY), while the FY2012 annual figure was -$11.4 million, down 194.08% from the prior year.
  • Change in Taxes was -$3.2 million for Q4 2012 at Vertex Pharmaceuticals, down from $3.7 million in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $3.7 million in Q3 2012 to a low of -$11.9 million in Q1 2012.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2012 -3.16 Mn
Dec 31, 2012 -3.16 Mn
Sep 30, 2012 3.67 Mn
Sep 30, 2012 3.67 Mn
Mar 31, 2012 -11.87 Mn
Mar 31, 2012 -11.87 Mn
Dec 31, 2011 2.32 Mn
Dec 31, 2011 2.32 Mn
Sep 30, 2011 -5.46 Mn
Sep 30, 2011 -5.46 Mn